Table of Contents

Dtsch Arztebl Int 2010; 107(17)

30 April 2010

Original article

The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences

Part 2. A Qualitative, Systematic Review of the Literature on Possible Influences on Authorship, Access to Trial Data, and Trial Registration and Publication
Schott, G; Pachl, H; Limbach, U; Gundert-Remy, U; Lieb, K; Ludwig, W

Correspondence

Useless Therapeutic Option

Lukowski, T

Correspondence

Use of Developed Products Preferable

Genzwürker, H; Gernoth, C; Hinkelbein, J

Correspondence

Isotonic Is Better

Seewi, O

Correspondence

Pay Attention to the Target Group

Mader, T

Correspondence

Additions Are Needed

Müller-Lobeck, L

Correspondence

Use Familiar Material

Strauß, J; Becke, K

Correspondence

In reply

Meyburg, J

cme

Gait Disturbances in Old Age

Classification, Diagnosis, and Treatment From a Neurological Perspective
Jahn, K; Zwergal, A; Schniepp, R

Deutsches Ärzteblatt international

Deutsches Ärzteblatt international